In subtype-stratified analyses, genetically proxied PPARG perturbation was weakly associated with lower risk of ER+ breast cancer (OR 0.57 [95% CI 0.38, 0.85], p=6.45×10−3). This evidence concerns the gene PPARG and breast carcinoma.